Asia-Pacific Proteomics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia-Pacific Proteomics Market is segmented by Type (Instrument, Reagents, Software and Services), Applications (Clinical Diagnostics, Drug Discovery, Other Applications), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

Asia-Pacific Proteomics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

APAC Proteomics Market Size

View Global Report
Asia-Pacific Proteomics Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2021 - 2023
CAGR 7.60 %
Market Concentration Medium

Major Players

Asia-Pacific Proteomics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Proteomics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

APAC Proteomics Market Analysis

The Asia-Pacific Proteomics Market is expected to register a CAGR of 7.6% during the forecast period.

During the COVID-19 pandemic, proteomics helped in various ways. Few market players undertook strategic initiatives during the pandemic, which boosted the market growth. For instance, in April 2021, Shionogi & Co., Ltd. and Sysmex Corporation reported that HISCL TARC Assay Kit, a Th2 chemokine (TARC) kit, was approved for an additional indication as an auxiliary for assessment of aggravation risk in patients testing positive for SARS-CoV-2. The development of therapeutic and preventive strategies requires an accurate understanding of proteins' role in the SARS-CoV-2 infection process and progression of COVID-19. However, due to the temporary shutdown of research institutes and less manpower, performing research activities normally during the COVID-19 pandemic was difficult. But, with time, the situation gradually improved, which is expected to support the market growth over the forecast period.

The widening applications of proteomics are contributing largely to market growth. For instance, according to the data from MDPI published in February 2021, proteomic analysis is one of the leading approaches with increasing significance in clinical applications that are associated with the development of high-performance instruments that allow for the identification of disease-specific biomarkers and rapid protein profiling of the analyzed samples. Therefore, with the implementation of proteomics for infectious disease therapeutics, the cell-free protein expression market is expected to grow during the study period.

Additionally, the involvement of the government in the betterment of the biotechnology industry is fueling the market growth. For instance, as per a May 2020 update by the India Brand Equity Foundation (IBEF), in the Union Budget 2022-23, the Department of Biotechnology was allotted Rs. 2,581 crores (USD 343.56 million) for developing basic infrastructure, genetic engineering, technologies, and bioinformatics, agriculture biotechnology, and training skilled professionals. This is anticipated to boost the number of research and development activities about protein identification and will contribute to the growth of the market studied.

However, the high cost of instruments is believed to hinder market growth over the forecast period.

APAC Proteomics Industry Overview

The Asia-Pacific proteomics market is moderately competitive, with the presence of global as well as a few local companies in the region. Some key companies in the market include Bruker Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, and GE Healthcare, among others.

APAC Proteomics Market Leaders

  1. Agilent Technologies, Inc.

  2. Bio-Rad Laboratories, Inc.

  3. Danaher Corporation

  4. GE Healthcare

  5. Thermofischer Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Proteomics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

APAC Proteomics Market News

  • In March 2022, Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, launched its expanded suite of protein platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early-stage discovery to clinical settings.
  • In January 2022, Illumina, Inc. entered into a definitive co-development agreement with SomaLogic to bring the SomaScan Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms in India.

APAC Proteomics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Personalized Medicine
    • 4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size - Value in USD million)

  • 5.1 By Type
    • 5.1.1 Instrument
    • 5.1.1.1 Spectroscopy
    • 5.1.1.2 Chromatography
    • 5.1.1.3 Electrophoresis
    • 5.1.1.4 Protein Microarrays
    • 5.1.1.5 X-Ray Crystallography
    • 5.1.1.6 Other Instrumentation Technologies
    • 5.1.2 Reagents
    • 5.1.3 Software and Services
  • 5.2 By Application
    • 5.2.1 Clinical Diagnostics
    • 5.2.2 Drug Discovery
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
    • 5.3.1.1 China
    • 5.3.1.2 Japan
    • 5.3.1.3 India
    • 5.3.1.4 Australia
    • 5.3.1.5 South Korea
    • 5.3.1.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies, Inc.
    • 6.1.2 Bio-Rad Laboratories, Inc.
    • 6.1.3 Bruker Corporation
    • 6.1.4 Danaher Corporation
    • 6.1.5 GE Healthcare
    • 6.1.6 Merck KGaA
    • 6.1.7 Promega Corporation
    • 6.1.8 Thermo Fisher Scientific, Inc.
    • 6.1.9 Waters Corporation
    • 6.1.10 Applied Biomics Inc.
    • 6.1.11 MRM Proteomics Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

APAC Proteomics Industry Segmentation

Proteomics is the study of protein structure and function. A proteome is a set of proteins produced in an organism, system, or biological context. The Asia-Pacific Proteomics Market is segmented by Type (Instrument (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Other Instrumentation Technologies), Reagents, Software and Services), Applications (Clinical Diagnostics, Drug Discovery, Other Applications), and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

By Type Instrument Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Other Instrumentation Technologies
Reagents
Software and Services
By Application Clinical Diagnostics
Drug Discovery
Other Applications
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

APAC Proteomics Market Research FAQs

What is the current Asia-Pacific Proteomics Market size?

The Asia-Pacific Proteomics Market is projected to register a CAGR of 7.6% during the forecast period (2025-2030)

Who are the key players in Asia-Pacific Proteomics Market?

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, GE Healthcare and Thermofischer Scientific Inc. are the major companies operating in the Asia-Pacific Proteomics Market.

What years does this Asia-Pacific Proteomics Market cover?

The report covers the Asia-Pacific Proteomics Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Proteomics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Proteomics Industry Report

Statistics for the 2025 Asia-Pacific Proteomics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Proteomics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.